---
document_datetime: 2025-06-19 17:33:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rizmoic-epar-all-authorised-presentations_en.pdf
document_name: rizmoic-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1035503
conversion_datetime: 2025-12-23 07:55:02.944664
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|----------------------------|
| EU/1/18/1291/001 | Rizmoic           | 200 µg     | Film-coated tablet    | Oral use                  | blister (OPA/alu/PVC/alu) | 7 tablets                  |
| EU/1/18/1291/002 | Rizmoic           | 200 µg     | Film-coated tablet    | Oral use                  | blister (OPA/alu/PVC/alu) | 28 tablets                 |
| EU/1/18/1291/003 | Rizmoic           | 200 µg     | Film-coated tablet    | Oral use                  | blister (OPA/alu/PVC/alu) | 84 tablets                 |
| EU/1/18/1291/004 | Rizmoic           | 200 µg     | Film-coated tablet    | Oral use                  | blister (OPA/alu/PVC/alu) | 10 tablets                 |
| EU/1/18/1291/005 | Rizmoic           | 200 µg     | Film-coated tablet    | Oral use                  | blister (OPA/alu/PVC/alu) | 30 tablets                 |
| EU/1/18/1291/006 | Rizmoic           | 200 µg     | Film-coated tablet    | Oral use                  | blister (OPA/alu/PVC/alu) | 100 tablets                |
| EU/1/18/1291/007 | Rizmoic           | 200 µg     | Film-coated tablet    | Oral use                  | blister (OPA/alu/PVC/alu) | 30 x 1 tablets (unit dose) |